NeOnc Technologies Holdings is trading 5.51% up at $2.87, with biotech-sector gains providing context but no confirmed direct cause. - No company-specific announcement dated October 20, 2026, was identified; the latest reported clinical update was October 16, about early improvement in a child receiving investigational NEO100. - XBI is reported up 2.10%, amid positive sector sentiment around M&A and clinical-trial developments.